Publications by authors named "Nazim S Turhal"

Claim this Profile
T
The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes.
Josien C C Scheepens, Mogens Groenvold, Johannes M Giesinger, Linda Dirven, Anna M M Thurner, Nazim Serdar Turhal

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival.
Halil İbrahim Ellez, Hüseyin Salih Semiz, Ferhat Ekinci, Atike Pınar Erdoğan, Fatih Kuş, Nazım Serdar Turhal

J Bone Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IV international prospective validation of the EORTC patient satisfaction core questionnaire (EORTC PATSAT-C33) and outpatient module (EORTC OUT-PATSAT7).
Anne Brédart, Jean-Luc Kop, Omar Shamieh, Louis Fox, Waleed Alrjoub, Nazim Serdar Turhal

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Seda Kahraman, Enes Erul, Ozge Gumusay, Deniz Can Guven, Sercan Aksoy, Nazim Serdar Turhal

Clin Breast Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the performance of the MSKCC gastric cancer survival calculator in the Turkish population.
İlknur Deliktaş Onur, Tuğba Başoğlu, Nazım Can Demircan, Tuğba Akin Telli, Rukiye Arikan, Nazım Serdar Turhal

Turk J Med Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.
Seda Kahraman, Mutlu Hizal, Burcin Cakan Demirel, Deniz Can Guven, Ozge Gumusay, Nazim Serdar Turhal

BMC Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?
Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Nazım Serdar Turhal

Curr Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG).
Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, Sema Sezgin Goksu, Irem Bilgetekin, Nazım Serdal Turhal

Clin Genitourin Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.
Saadettin Kilickap, Akin Ozturk, Nuri Karadurmus, Taner Korkmaz, Perran Fulden Yumuk, Nazim Serdar Turhal

Medicine (Baltimore)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
Elvina Almuradova, Mustafa Seyyar, Hacı Arak, Fatih Tamer, Umut Kefeli, Nazım Serdar Turhal

Int J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Nazım Serdar Turhal

BMC Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Nazım Serdar Turhal

BMC Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major and minor salivary gland cancers: A multicenter retrospective study.
Muhammet Bekir Hacioglu, Bulent Erdogan, Murat Bardakcı, Efnan Algın, Burcu Gulbagcı, Nazım Serdar Turhal

Head Neck· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire.
Samantha C Sodergren, Colin D Johnson, Alexandra Gilbert, Anne-Sophie Darlington, Kim Cocks, Nazim S Turhal

Int J Radiat Oncol Biol Phys· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Seda Kahraman, Enes Erul, Mustafa Seyyar, Ozge Gumusay, Ertugrul Bayram, Nazim Serdar Turhal

Future Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group.
Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş, Elif Berna Köksoy, Naziyet Köse, Nazım Serdar Turhal

J Cancer Res Clin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.
Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Nazim Serdar Turhal

Bosn J Basic Med Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray, Nazım Serdar Turhal

J Gastrointest Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic colorectal cancer in both sides of Aegean sea: practice patterns and outcome.
Ozan Yazici, Gokhan Ucar, Osman Sütcüoglu, Nazım Serdar Turhal, Birol Yildiz

Curr Med Res Opin· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray, Nazım Serdar Turhal

Tumori· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data.
Nuriye Özdemir, Ömer Dizdar, Ozan Yazıcı, Sercan Aksoy, Didem Sener Dede, Nazim Serdar Turhal

Int J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases.
Zeynep Oruç, M Ali Kaplan, Mustafa Karaağaç, Neslihan Özyurt, Ali Murat Tatlı, Nazım Serdar Turhal

Future Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging and clinical correlates with regorafenib in metastatic colorectal cancer.
Khurum Khan, Stefano Cascinu, David Cunningham, Sun-Young Kim, Eiji Oki, Nazim Serdar Turhal

Cancer Treat Rev· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial.
Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal

Balkan Med J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study.
Levent Korkmaz, Hasan Şenol Coşkun, Faysal Dane, Bülent Karabulut, Mustafa Karaağaç, Nazım Serdar Turhal

Surg Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis